In the study published in the journal Emerging Microbes and Infections, the team demonstrated that the patented therapeutic candidate, an HIV-virus-like-particle (HLP), is 100 times more effective ...
Using a DNA-based delivery particle, researchers created a vaccine that can induce a strong antibody response against SARS-CoV-2. Using a virus-like delivery particle made from DNA, researchers from ...
The CDC's Advisory Committee on Immunization Practices (ACIP) unanimously recommended that U.S. travelers ages 12 years and older receive the virus-like particle chikungunya vaccine (Vimkunya) when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results